Skip to content

Prospective study on active surveillance of low-risk papillary thyroid carcinoma

Prospective study on active surveillance of low-risk papillary thyroid carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035084
Enrollment
Unknown
Registered
2020-07-30
Start date
2021-01-02
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low-risk papillary thyroid carcinoma

Interventions

case series:active surveillance

Sponsors

The First hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 20-75 years old; 2. Puncture pathology confirmed papillary thyroid carcinoma; Non high columnar cell type. Or patients with C-TIRADS grade 5 who refuse to undergo puncture diagnosis. 3.Ultrasound examination indicates that all of the following conditions are met: tumor <= 10mm, no invasion of thyroid capsule, not close to trachea and posterior thyroid capsule (recurrent laryngeal nerve position), and no metastatic lymph nodes; 4. Not participating in other similar studies; 5.Patients who meet the above conditions are willing to choose dynamic observation rather than immediate surgical treatment.

Exclusion criteria

Exclusion criteria: 1. Puncture diagnosis of thyroid cancer, but not papillary carcinoma; 2.Thyroid cancer larger than 10mm; 3.Those that do not meet the low-risk characteristics indicated by ultrasound, such as tumor invasion of the thyroid capsule, adhesion to the trachea, suspected lymph node metastasis, etc; 4. Mental tension and unwillingness to choose observers.

Design outcomes

Primary

MeasureTime frame
Disease Specific Mortality;

Secondary

MeasureTime frame
Recurrence Rate;Quality of Life;

Countries

China

Contacts

Public ContactGuang Chen

Department of Thyroid Surgery, the First Hospital of Jilin University

jidayiyuanjzx@sina.com+86 137 5666 1294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026